Skip to main content

Re: Prevalence and Prognosis of Low-volume, Oligorecurrent, Hormone-sensitive Prostate Cancer Amenable to Lesion Ablative Therapy.

Division: 
Citation: 

Aminsharifi, Alireza, and Thomas J. Polascik. “Re: Prevalence and Prognosis of Low-volume, Oligorecurrent, Hormone-sensitive Prostate Cancer Amenable to Lesion Ablative Therapy..” Eur Urol 74, no. 2 (August 2018): 234–35. https://doi.org/10.1016/j.eururo.2018.01.022.

Published Date: 
Wednesday, August 1, 2018
Published In: 
Eur Urol
PMID: 
29428367